Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01666938
Other study ID # CSE-1410/2011
Secondary ID
Status Completed
Phase N/A
First received August 14, 2012
Last updated March 23, 2013
Start date April 2012
Est. completion date November 2012

Study information

Verified date March 2013
Source University of Sao Paulo
Contact n/a
Is FDA regulated No
Health authority Brazil: Ethics Committee
Study type Interventional

Clinical Trial Summary

The purpose of this study is to investigate the effects of phone counselling support as a strategy to increase physical activity in people with diabetes.


Recruitment information / eligibility

Status Completed
Enrollment 26
Est. completion date November 2012
Est. primary completion date September 2012
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria:

- Clinical diagnosis of type 2 diabetes mellitus

- age between 18 and 80 years

- both sexes

- medical recommendation for physical activity

- ability to listen and answer questions

- have cell phone and/or residential

- be registered the Center for Family Health 03 in 2012

- People should also produce higher frequency than 75% stake in the proposed activities Diabetes Education Group and telephone counseling

Exclusion Criteria: People who do not attend the criteria for inclusion.

- did not have clinical diagnosis of type 2 diabetes mellitus

- did not have age between 18 and 80 years

- did not have medical recommendation for physical activity

- did not have ability to listen and answer questions

- did not have cell phone and/or residential

- do not be registered the Center for Family Health 03 in 2012

- People who did not participate in 75% of the activities of the Group proposed the Diabetes Education and telephone counseling

Study Design

Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care


Related Conditions & MeSH terms


Intervention

Other:
Diabetes Education Group
Diabetes Education Group: Diabetes Education for four month, one time per week.
Telephone Counseling
Telephone counseling: 12 phone calls for four months about physical activity. During the first and second month, was done four phone calls each month. During the third and fourth month, was done two phone calls per month.

Locations

Country Name City State
Brazil Center for Family Health 03 Ribeirao Preto Sao Paulo

Sponsors (1)

Lead Sponsor Collaborator
University of Sao Paulo

Country where clinical trial is conducted

Brazil, 

Outcome

Type Measure Description Time frame Safety issue
Primary level of physical activity It was used the international physical activity questionnaire (IPAQ) to classify the level of physical activity four months No
Secondary Metabolic Control Body Mass Index
Waist Circumference
Mean Systolic Blood Pressure
Mean Diastolic Blood Pressure
Fasting Glucose
Low Density Lipoprotein (LDL)
High Density Lipoprotein
Total Cholesterol
Triglycerides
Glycated Hemoglobin
Four Months No
See also
  Status Clinical Trial Phase
Completed NCT03743779 - Mastering Diabetes Pilot Study
Completed NCT03786978 - Pharmaceutical Care in the Reduction of Readmission Rates in Diabetes Melitus N/A
Completed NCT01804803 - DIgital Assisted MONitoring for DiabeteS - I N/A
Completed NCT05039970 - A Real-World Study of a Mobile Device-based Serious Health Game on Session Attendance in the National Diabetes Prevention Program N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Completed NCT04068272 - Safety of Bosentan in Type II Diabetic Patients Phase 1
Completed NCT03243383 - Readmission Prevention Pilot Trial in Diabetes Patients N/A
Completed NCT03730480 - User Performance of the CONTOUR NEXT and CONTOUR TV3 Blood Glucose Monitoring System (BGMS) N/A
Recruiting NCT02690467 - Efficacy, Safety and Acceptability of the New Pen Needle 34gx3,5mm. N/A
Completed NCT02229383 - Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus Phase 3
Completed NCT05799976 - Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure N/A
Completed NCT06181721 - Evaluating Glucose Control Using a Next Generation Automated Insulin Delivery Algorithm in Patients With Type 1 and Type 2 Diabetes N/A
Recruiting NCT04489043 - Exercise, Prediabetes and Diabetes After Renal Transplantation. N/A
Withdrawn NCT03319784 - Analysis for NSAID VS Corticosteroid Shoulder Injection in Diabetic Patients Phase 4
Completed NCT03542084 - Endocrinology Auto-Triggered e-Consults N/A
Completed NCT02229396 - Phase 3 28-Week Study With 24-Week and 52-week Extension Phases to Evaluate Efficacy and Safety of Exenatide Once Weekly and Dapagliflozin Versus Exenatide and Dapagliflozin Matching Placebo Phase 3
Recruiting NCT05544266 - Rare and Atypical Diabetes Network
Completed NCT01892319 - An International Non-interventional Cohort Study to Evaluate the Safety of Treatment With Insulin Detemir in Pregnant Women With Diabetes Mellitus. Diabetes Pregnancy Registry
Completed NCT05031000 - Blood Glucose Monitoring Systems: Discounter Versus Brand N/A
Recruiting NCT04039763 - RT-CGM in Young Adults at Risk of DKA N/A